DZ3197A1 - Acides aminés bicycliques utilises comme agents pharmaceutiques. - Google Patents

Acides aminés bicycliques utilises comme agents pharmaceutiques.

Info

Publication number: DZ3197A1
Authority: DZ; Algeria
Prior art keywords: amino acids; pharmaceutical agents; acids used; bicyclic amino; bicyclic
Prior art date: 1999-10-20

Application number

DZ003197A

Other languages

English (en)

French (fr)

Inventor

Justin Stephen Bryans

David Clive Blakemore

Simon Osborne

Jean-Marie Receveur

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-20

Filing date

2000-10-17

Publication date

2001-04-26

2000-10-17 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2001-04-26 Application granted granted Critical

2001-04-26 Publication of DZ3197A1 publication Critical patent/DZ3197A1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/18—All rings being cycloaliphatic the ring system containing six carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/20—All rings being cycloaliphatic the ring system containing seven carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/22—All rings being cycloaliphatic the ring system containing eight carbon atoms, e.g. pentalene
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
- C07C2602/28—Hydrogenated naphthalenes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Psychology (AREA)
Epidemiology (AREA)
Hematology (AREA)
Anesthesiology (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Immunology (AREA)
Obesity (AREA)
Vascular Medicine (AREA)
Reproductive Health (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)

DZ003197A 1999-10-20 2000-10-17 Acides aminés bicycliques utilises comme agents pharmaceutiques. DZ3197A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US16072599P	1999-10-20	1999-10-20
PCT/US2000/028687 WO2001028978A1 (en)	1999-10-20	2000-10-17	Bicyclic amino acids as pharmaceutical agents

Publications (1)

Publication Number	Publication Date
DZ3197A1 true DZ3197A1 (fr)	2001-04-26

Family

ID=22578159

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ003197A DZ3197A1 (fr)	1999-10-20	2000-10-17	Acides aminés bicycliques utilises comme agents pharmaceutiques.

Country Status (50)

Country	Link
US (2)	US6689906B1 (xx)
EP (2)	EP1226110B1 (xx)
JP (2)	JP3632191B2 (xx)
KR (2)	KR100566462B1 (xx)
CN (1)	CN1165518C (xx)
AP (2)	AP2002002517A0 (xx)
AR (2)	AR026087A1 (xx)
AT (2)	ATE293590T1 (xx)
AU (2)	AU778871B2 (xx)
BG (2)	BG108860A (xx)
BR (1)	BR0014972B1 (xx)
CA (1)	CA2386297C (xx)
CO (1)	CO5280060A1 (xx)
CR (1)	CR6620A (xx)
CU (1)	CU23112A3 (xx)
CZ (1)	CZ295960B6 (xx)
DE (2)	DE60034157T2 (xx)
DO (1)	DOP2000000083A (xx)
DZ (1)	DZ3197A1 (xx)
EA (1)	EA005206B1 (xx)
EC (1)	ECSP045393A (xx)
EE (1)	EE200200211A (xx)
ES (2)	ES2282785T3 (xx)
GE (1)	GEP20043297B (xx)
GT (2)	GT200000183A (xx)
HK (1)	HK1049826B (xx)
HN (1)	HN2000000224A (xx)
HR (2)	HRP20040709A2 (xx)
HU (1)	HUP0203325A3 (xx)
IL (3)	IL164060A0 (xx)
IS (2)	IS6348A (xx)
MA (1)	MA26842A1 (xx)
MX (1)	MXPA02003229A (xx)
MY (1)	MY127678A (xx)
NO (2)	NO20021780D0 (xx)
NZ (1)	NZ517961A (xx)
OA (1)	OA12070A (xx)
PA (1)	PA8505201A1 (xx)
PE (1)	PE20010740A1 (xx)
PL (1)	PL354607A1 (xx)
PT (1)	PT1226110E (xx)
SI (1)	SI1226110T1 (xx)
SK (1)	SK5232002A3 (xx)
SV (1)	SV2001000188A (xx)
TR (2)	TR200201094T2 (xx)
TW (2)	TW200505824A (xx)
UA (1)	UA72931C2 (xx)
WO (1)	WO2001028978A1 (xx)
YU (2)	YU29302A (xx)
ZA (1)	ZA200202543B (xx)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7164034B2 (en)	1999-06-10	2007-01-16	Pfizer Inc.	Alpha2delta ligands for fibromyalgia and other disorders
CN1279900C (zh) *	2000-06-26	2006-10-18	沃尼尔·朗伯公司	用于睡眠障碍的加巴喷丁类似物
US6620829B2 (en)	2000-10-17	2003-09-16	Warner-Lambert Company	Method of treating noninflammatory cartilage damage
EP1226820A1 (en) *	2001-01-26	2002-07-31	Warner-Lambert Company	Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders
NZ528151A (en) *	2001-04-19	2005-04-29	Warner Lambert Co	Fused bicyclic or tricyclic amino acids
GB2375109A (en) *	2001-05-04	2002-11-06	Warner Lambert Co	Process for preparing bicyclic amino acid
GB2375108A (en) *	2001-05-04	2002-11-06	Warner Lambert Co	Production of a bicycloheptanone
US7232924B2 (en)	2001-06-11	2007-06-19	Xenoport, Inc.	Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
CN1533270A (zh) *	2001-06-11	2004-09-29	ʲŵ��޹�˾	具有降低毒性的gaba类似物前药的口服给药剂型
US7186855B2 (en)	2001-06-11	2007-03-06	Xenoport, Inc.	Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en)	2001-06-11	2004-11-16	Xenoport, Inc.	Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en)	2005-04-06	2011-11-01	Xenoport, Inc.	Prodrugs of GABA analogs, compositions and uses thereof
WO2003063845A1 (en)	2002-01-31	2003-08-07	Warner-Lambert Company Llc	Alpha 2 delta ligands to treat tinnitus
CA2476438A1 (en) *	2002-02-22	2003-08-28	Warner-Lambert Company Llc	Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
WO2004002462A2 (en) *	2002-06-27	2004-01-08	Warner-Lambert Company Llc	Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder
US7419981B2 (en)	2002-08-15	2008-09-02	Pfizer Inc.	Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
GB0219024D0 (en) *	2002-08-15	2002-09-25	Pfizer Ltd	Synergistic combinations
BR0313432A (pt) *	2002-08-15	2005-07-12	Pfizer	Uso terapêutico de aminoácidos bicìclicos ou tricìclicos fundidos
GB0223072D0 (en)	2002-10-04	2002-11-13	Pfizer Ltd	Cyclic nitromethyl acetic acid derivatives
US7018818B2 (en)	2002-10-04	2006-03-28	Pfizer Inc.	Intermediates in the preparation of therapeutic fused bicyclic amino acids
US7060727B2 (en)	2002-12-11	2006-06-13	Xenoport, Inc.	Prodrugs of fused GABA analogs, pharmaceutical compositions and uses thereof
CA2679030A1 (en)	2002-12-13	2004-07-01	Warner-Lambert Company Llc	Alpha-2-delta ligand to treat lower urinary track symptoms
CA2451267A1 (en)	2002-12-13	2004-06-13	Warner-Lambert Company Llc	Pharmaceutical uses for alpha2delta ligands
WO2004054566A1 (en)	2002-12-13	2004-07-01	Warner-Lambert Company Llc	Pregabalin derivatives for the treatment of fibromyalgia and other disorders
KR100828218B1 (ko)	2003-09-12	2008-05-07	화이자 인코포레이티드	알파-2-델타 리간드 및 세로토닌/노르아드레날린 재흡수 억제제를 포함하는 조합물
WO2006092692A1 (en) *	2005-03-01	2006-09-08	Pfizer Limited	Use of combinations of pde7 inhibitors and alpha-2-delty ligands for the treatment of neuropathic pain
AR061728A1 (es) *	2006-06-30	2008-09-17	Pfizer Prod Inc	Composicion para tratamiento usando compuestos selectivos alfa-2-delta-1
HRP20110634T1 (hr)	2006-12-22	2011-10-31	Recordati Ireland Limited	KOMBINIRANA TERAPIJA LIGANADA α<SUB>2</SUB>δ I NSAID ZA POREMEĆAJE DONJEG URINARNOG TRAKTA
MY153910A (en)	2007-09-28	2015-04-15	Daiichi Sankyo Co Ltd	BICYCLIC y-AMINO ACID DERIVATIVE
JP5557292B2 (ja)	2009-03-26	2014-07-23	第一三共株式会社	二環性γ−アミノ酸誘導体の製造方法
EP2719676B1 (en)	2011-06-08	2017-12-13	Daiichi Sankyo Company, Limited	Method for producing bicyclic compound via iminium salt
CN103562170B (zh)	2011-06-08	2015-09-02	第一三共株式会社	经由克莱森重排制备双环化合物的方法
JP6017451B2 (ja)	2011-12-15	2016-11-02	第一三共株式会社	不斉触媒を用いる二環性化合物の光学分割方法
WO2013154066A1 (ja)	2012-04-10	2013-10-17	第一三共株式会社	酵素を用いる二環性化合物の光学分割方法
US9066853B2 (en)	2013-01-15	2015-06-30	Warsaw Orthopedic, Inc.	Clonidine compounds in a biodegradable fiber
TWI635071B (zh)	2013-07-08	2018-09-11	第一三共股份有限公司	光學活性二環γ－胺基酸衍生物及其製造方法
WO2018166855A1 (en)	2017-03-16	2018-09-20	Basf Se	Heterobicyclic substituted dihydroisoxazoles
CN113045410A (zh) *	2021-03-29	2021-06-29	华东理工大学	一种双环降二萜类化合物及其合成基因及制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3641129A (en) *	1969-06-17	1972-02-08	Merck & Co Inc	Antifibrinolytic compounds
US4087544A (en) *	1974-12-21	1978-05-02	Warner-Lambert Company	Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) *	1974-12-21	1982-09-23	Gödecke AG, 1000 Berlin	1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
GEP20094817B (en)	1997-10-27	2009-11-10	Warner Lambert Co	Cyclic amino acids and derivatives thereof useful as pharmaceutical agents

2000
- 2000-10-05 HN HN2000000224A patent/HN2000000224A/es unknown
- 2000-10-06 SV SV2000000188A patent/SV2001000188A/es not_active Application Discontinuation
- 2000-10-17 YU YU29302A patent/YU29302A/sh unknown
- 2000-10-17 AP APAP/P/2002/002517A patent/AP2002002517A0/en unknown
- 2000-10-17 DZ DZ003197A patent/DZ3197A1/xx active
- 2000-10-17 DE DE60034157T patent/DE60034157T2/de not_active Expired - Lifetime
- 2000-10-17 IL IL16406000A patent/IL164060A0/xx unknown
- 2000-10-17 KR KR1020067002249A patent/KR100566462B1/ko not_active Expired - Fee Related
- 2000-10-17 US US10/130,023 patent/US6689906B1/en not_active Expired - Fee Related
- 2000-10-17 ES ES04027485T patent/ES2282785T3/es not_active Expired - Lifetime
- 2000-10-17 GE GE4783A patent/GEP20043297B/en unknown
- 2000-10-17 OA OA1200200117A patent/OA12070A/en unknown
- 2000-10-17 SK SK523-2002A patent/SK5232002A3/sk unknown
- 2000-10-17 HR HRP20040709 patent/HRP20040709A2/xx not_active Application Discontinuation
- 2000-10-17 SI SI200030670T patent/SI1226110T1/xx unknown
- 2000-10-17 AP AP2004003186A patent/AP2004003186A0/xx unknown
- 2000-10-17 BR BRPI0014972-1A patent/BR0014972B1/pt not_active IP Right Cessation
- 2000-10-17 EP EP00972226A patent/EP1226110B1/en not_active Expired - Lifetime
- 2000-10-17 AT AT00972226T patent/ATE293590T1/de not_active IP Right Cessation
- 2000-10-17 UA UA2002032434A patent/UA72931C2/uk unknown
- 2000-10-17 ES ES00972226T patent/ES2237464T3/es not_active Expired - Lifetime
- 2000-10-17 MX MXPA02003229A patent/MXPA02003229A/es active IP Right Grant
- 2000-10-17 TR TR2002/01094T patent/TR200201094T2/xx unknown
- 2000-10-17 CN CNB008145644A patent/CN1165518C/zh not_active Expired - Fee Related
- 2000-10-17 AU AU10920/01A patent/AU778871B2/en not_active Ceased
- 2000-10-17 DE DE60019628T patent/DE60019628T2/de not_active Expired - Lifetime
- 2000-10-17 EA EA200200293A patent/EA005206B1/ru unknown
- 2000-10-17 TR TR2005/00221T patent/TR200500221T2/xx unknown
- 2000-10-17 WO PCT/US2000/028687 patent/WO2001028978A1/en active IP Right Grant
- 2000-10-17 EE EEP200200211A patent/EE200200211A/xx unknown
- 2000-10-17 EP EP04027485A patent/EP1506955B1/en not_active Expired - Lifetime
- 2000-10-17 PL PL00354607A patent/PL354607A1/xx not_active Application Discontinuation
- 2000-10-17 AT AT04027485T patent/ATE358116T1/de not_active IP Right Cessation
- 2000-10-17 CA CA2386297A patent/CA2386297C/en not_active Expired - Fee Related
- 2000-10-17 HR HR20020428A patent/HRP20020428B1/xx not_active IP Right Cessation
- 2000-10-17 NZ NZ517961A patent/NZ517961A/xx unknown
- 2000-10-17 PT PT00972226T patent/PT1226110E/pt unknown
- 2000-10-17 CZ CZ20021310A patent/CZ295960B6/cs not_active IP Right Cessation
- 2000-10-17 IL IL14914300A patent/IL149143A0/xx not_active IP Right Cessation
- 2000-10-17 JP JP2001531783A patent/JP3632191B2/ja not_active Expired - Fee Related
- 2000-10-17 KR KR1020027005036A patent/KR100593349B1/ko not_active Expired - Fee Related
- 2000-10-17 HU HU0203325A patent/HUP0203325A3/hu unknown
- 2000-10-17 HK HK03101868.4A patent/HK1049826B/zh not_active IP Right Cessation
- 2000-10-17 YU YU73004A patent/YU73004A/sh unknown
- 2000-10-18 PA PA20008505201A patent/PA8505201A1/es unknown
- 2000-10-18 MY MYPI20004896A patent/MY127678A/en unknown
- 2000-10-19 DO DO2000000083A patent/DOP2000000083A/es unknown
- 2000-10-19 GT GT200000183A patent/GT200000183A/es unknown
- 2000-10-19 PE PE2000001116A patent/PE20010740A1/es not_active Application Discontinuation
- 2000-10-19 AR ARP000105497A patent/AR026087A1/es unknown
- 2000-10-19 CO CO00079741A patent/CO5280060A1/es not_active Application Discontinuation
- 2000-10-19 GT GT200000183AK patent/GT200000183AA/es unknown
- 2000-10-20 TW TW093125953A patent/TW200505824A/zh unknown
- 2000-10-20 TW TW089122115A patent/TWI225855B/zh not_active IP Right Cessation
2002
- 2002-03-28 ZA ZA200202543A patent/ZA200202543B/xx unknown
- 2002-04-15 IL IL149143A patent/IL149143A/en unknown
- 2002-04-16 CU CU78A patent/CU23112A3/es unknown
- 2002-04-16 NO NO20021780A patent/NO20021780D0/no not_active Application Discontinuation
- 2002-04-17 IS IS6348A patent/IS6348A/is unknown
- 2002-04-18 CR CR6620A patent/CR6620A/es not_active Application Discontinuation
- 2002-05-10 MA MA26634A patent/MA26842A1/fr unknown
- 2002-05-20 BG BG108860A patent/BG108860A/en unknown
- 2002-05-20 BG BG106719A patent/BG106719A/bg unknown
2004
- 2004-01-21 US US10/762,026 patent/US6835751B2/en not_active Expired - Fee Related
- 2004-07-28 EC EC2004005393A patent/ECSP045393A/es unknown
- 2004-08-17 AR ARP040102937A patent/AR045456A2/es unknown
- 2004-09-01 NO NO20043663A patent/NO20043663L/no not_active Application Discontinuation
- 2004-09-14 JP JP2004266488A patent/JP3744928B2/ja not_active Expired - Fee Related
- 2004-10-08 IS IS7497A patent/IS7497A/is unknown
2005
- 2005-03-23 AU AU2005201268A patent/AU2005201268A1/en not_active Abandoned

Also Published As

Publication number	Publication date
HN2000000224A (es)	2001-04-11
US6835751B2 (en)	2004-12-28
BG108860A (en)	2006-03-31
AP2004003186A0 (en)	2004-12-31
DE60034157T2 (de)	2007-12-13
WO2001028978A1 (en)	2001-04-26
EP1506955A1 (en)	2005-02-16
ATE293590T1 (de)	2005-05-15
OA12070A (en)	2003-11-10
HUP0203325A2 (hu)	2003-02-28
BG106719A (bg)	2003-02-28
KR100593349B1 (ko)	2006-06-26
DE60019628T2 (de)	2006-01-19
YU73004A (sh)	2005-11-28
IS7497A (is)	2004-10-08
AR045456A2 (es)	2005-10-26
US20040152779A1 (en)	2004-08-05
IL164060A0 (en)	2005-12-18
BR0014972B1 (pt)	2011-09-06
CO5280060A1 (es)	2003-05-30
IL149143A0 (en)	2002-11-10
DE60034157D1 (de)	2007-05-10
JP2005036009A (ja)	2005-02-10
EP1226110B1 (en)	2005-04-20
HRP20020428B1 (en)	2006-02-28
DE60019628D1 (de)	2005-05-25
KR100566462B1 (ko)	2006-03-31
CN1165518C (zh)	2004-09-08
HK1049826A1 (en)	2003-05-30
EP1226110A1 (en)	2002-07-31
KR20060013701A (ko)	2006-02-13
EE200200211A (et)	2003-06-16
NZ517961A (en)	2002-12-20
JP2003512348A (ja)	2003-04-02
PT1226110E (pt)	2005-07-29
CA2386297A1 (en)	2001-04-26
CU23112A3 (es)	2006-02-27
EA200200293A1 (ru)	2002-10-31
NO20021780L (no)	2002-04-16
CN1382118A (zh)	2002-11-27
CZ20021310A3 (cs)	2003-05-14
JP3744928B2 (ja)	2006-02-15
US6689906B1 (en)	2004-02-10
TW200505824A (en)	2005-02-16
HRP20020428A2 (en)	2005-02-28
UA72931C2 (uk)	2005-05-16
HRP20040709A2 (en)	2004-12-31
EA005206B1 (ru)	2004-12-30
CR6620A (es)	2004-02-02
JP3632191B2 (ja)	2005-03-23
AU1092001A (en)	2001-04-30
ATE358116T1 (de)	2007-04-15
CA2386297C (en)	2010-02-09
SI1226110T1 (en)	2005-08-31
MXPA02003229A (es)	2002-09-30
AR026087A1 (es)	2002-12-26
YU29302A (sh)	2005-06-10
ES2237464T3 (es)	2005-08-01
TR200500221T2 (tr)	2005-03-21
AP2002002517A0 (en)	2002-06-30
AU2005201268A1 (en)	2005-04-21
HK1049826B (zh)	2005-02-25
TR200201094T2 (tr)	2002-09-23
EP1506955B1 (en)	2007-03-28
GT200000183AA (es)	2005-06-17
TWI225855B (en)	2005-01-01
CZ295960B6 (cs)	2005-12-14
MA26842A1 (fr)	2004-12-20
HUP0203325A3 (en)	2003-12-29
PE20010740A1 (es)	2001-07-27
PL354607A1 (en)	2004-01-26
IL149143A (en)	2007-02-11
NO20043663L (no)	2002-04-16
SK5232002A3 (en)	2003-07-01
BR0014972A (pt)	2002-07-16
AU778871B2 (en)	2004-12-23
NO20021780D0 (no)	2002-04-16
ES2282785T3 (es)	2007-10-16
DOP2000000083A (es)	2002-03-30
ECSP045393A (es)	2004-10-23
PA8505201A1 (es)	2002-08-29
IS6348A (is)	2002-04-17
GEP20043297B (en)	2004-01-12
GT200000183A (es)	2000-10-19
ZA200202543B (en)	2003-09-23
KR20020040900A (ko)	2002-05-30
MY127678A (en)	2006-12-29
SV2001000188A (es)	2001-09-07

Publication	Publication Date	Title
DZ3197A1 (fr)	2001-04-26	Acides aminés bicycliques utilises comme agents pharmaceutiques.
DZ3506A1 (fr)	2002-11-28	Derives de pyrrole utilises comme agents pharmaceutiques
NO20002217D0 (no)	2000-04-28	Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
ID24654A (id)	2000-07-27	Formulasi farmasi omeprazola
ATE447947T1 (de)	2009-11-15	Pharmazeutische zubereitungen zur behandlung von insulinresitenz
DK1212327T3 (da)	2003-12-15	Pyrazolopyrimidiner som terapeutiske midler
PT1147083E (pt)	2004-09-30	Derivados de arilpiperazinil-ciclohexilindole para o tratamento da depressao
FIU20000164U0 (fi)	2000-04-11	Uusi farmaseuttinen formulaatio
EP1218000A4 (en)	2003-07-09	NITRO FATTY ACIDS AND THIA AS ANTI-CANCER AGENTS
PT1240172E (pt)	2005-02-28	Novos acidos aminopropilfosfinicos
NO20016006D0 (no)	2001-12-07	Valensplattformmolekyler som innbefatter aminooksygrupper
EE04747B1 (et)	2006-12-15	Amiini-plaatina komplekside valmistamismeetod
IT1317741B1 (it)	2003-07-15	Metodo per la preparazione di 5-cianoftalide.
PT1206436E (pt)	2004-12-31	Retinoides para o tratamento de enfisema
IT1319251B1 (it)	2003-09-26	Metodo per la preparazione di 5-carbossiftalide.
IT1311921B1 (it)	2002-03-20	Composti farmaceutici.
FR2802423B1 (fr)	2005-03-25	Compositions pharmaceutiques
DK1227817T3 (da)	2004-11-15	Ciclesonid-holdigt vandigt farmaceutisk præparat
ID30032A (id)	2001-11-01	Formulasi farmasi
AR025867A1 (es)	2002-12-18	Formulacion portasdora farmaceutica
IT1313660B1 (it)	2002-09-09	Procedimento stereoselettivo per la preparazione di endo-3-amminoazabicicloalcani.
DK1226110T3 (da)	2005-06-27	Bicycliske aminosyrer som farmaceutiske midler
DZ2764A1 (fr)	2004-07-04	Acides indoléalcanoïques substitués.
ITMI991329A0 (it)	1999-06-15	Procedimento per la preparazione di tetrafluoroalogenobenzeni
IT1306195B1 (it)	2001-05-30	Composizioni cosmetiche ad uso topico comprendenti amminoacidiessenziali.